Cancer Drug Resistance: Why Treatments Fail Some Patients

Cancer’s Hidden Pathways: How ‘Backdoor’ Genes Are Reshaping Treatment Strategies Nearly half of all cancer patients don’t respond to the therapies they receive. For decades, this frustrating reality has fueled research into why some tumors are stubbornly resistant. Now, a groundbreaking study from MIT, building on work from ScienceDaily, MIT News, National Today, and ThePrint, … Read more